Fluciclovine f-18
Fluciclovine F-18 is a radiopharmaceutical agent used in Positron Emission Tomography (PET) imaging. It is primarily used to detect recurrent prostate cancer. Fluciclovine F-18 is a synthetic amino acid that is labeled with the radioactive isotope Fluorine-18.
History[edit]
Fluciclovine F-18 was approved by the United States Food and Drug Administration (FDA) in May 2016. It was developed by the pharmaceutical company Blue Earth Diagnostics.
Mechanism of Action[edit]
Fluciclovine F-18 works by mimicking the natural amino acids in the body. Cancer cells, which have a higher metabolic rate than normal cells, take up these synthetic amino acids at a higher rate. The radioactive isotope Fluorine-18 attached to the amino acid emits positrons, which are detected by the PET scanner to create an image of the body's tissues and organs.
Uses[edit]
Fluciclovine F-18 is used in PET imaging to detect recurrent prostate cancer. It is particularly useful in cases where other imaging techniques, such as Computed Tomography (CT) scans or Magnetic Resonance Imaging (MRI), are inconclusive.
Side Effects[edit]
Common side effects of Fluciclovine F-18 include headache, nausea, and a flushed feeling. As with all radiopharmaceuticals, there is a small risk of radiation exposure.
See Also[edit]
| Diagnostic radiopharmaceuticals (V09) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Prostate cancer | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This prostate cancer related article is a stub.
|
| Medical imaging | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
* Category
|
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
